TerminatedPhase 2NCT04128371
Mepolizumab in Episodic Angioedema With Eosinophilia
Studying Non-histaminic angioedema
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Principal Investigator
- Paneez Khoury, M.D.National Institute of Allergy and Infectious Diseases (NIAID)
- Intervention
- mepolizumab(biological)
- Enrollment
- 5 target
- Eligibility
- 18 years · All sexes
- Timeline
- 2021 – 2022
Study locations (1)
- National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04128371 on ClinicalTrials.gov